Giving Compass
  • Sign In
  • About Us
    About Giving Compass How We Choose Content and Organizations Annual Reflections Our Newsletter
    Collaboration Options
    Nonprofits Authors Use Our Content Services Contact Us
  • Getting Started
    Getting Started with Our Resources
    Donor Guides
    Philanthropy Resource Directory Giving Best Practices Guide to Nonprofit Ratings
  • Learn About Issues
    Topic Guides
    Animal Welfare COVID-19 Criminal Justice Disaster Relief Education Environment Health Homelessness Immigrants and Refugees Racial Equity Women and Girls
    Special Coverage
    Climate Change & Migration Climate Justice Digital Equity Education Indigenous Peoples LGBTQIA+ Mental Health Racial Justice Resources Reproductive Justice Strengthening Democracy
    Curated Articles
    Partner Collections Giving Compass Selections See All Articles
  • Give to Causes
    Issue Funds & Intermediaries Projects Nonprofits Giving Circle Directory
  • Get Involved
    Events Volunteer Opportunities
  • Solutions
  • Donate
  • Privacy Policy
  • Terms of Use
Donate
  • Get the Newsletter
  • Sign In
  • Or
  • Register
Category:

Diseases and Cures

  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    Gates Investing in Alzheimer’s Disease

    Medium Nov 19, 2017

    Bill Gates announced this week that he’s ploughing $100m (£76m) into research to find a breakthrough for Alzheimer’s disease. The initial $50m will be invested in a venture capital fund called…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    Putting Communities at the Center of Disease Prevention

    Devex Nov 16, 2017

    In late August, a man traveling on a small, packed bus headed for the Malagasy capital, Antananarivo, passed away suddenly of respiratory failure. His body was taken to the nearest…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    It’s Time to Face the Tuberculosis Crisis

    Devex International Development Nov 15, 2017

    The major global health crises of recent decades have, at times, felt insurmountable. The onset of the HIV epidemic in the late 1970s and the 2014 West African Ebola outbreak…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    Person-Centered Dementia Care Matters [Video]

    Dementia Action Alliance Nov 14, 2017

    Every once in a while something special comes along that has the power to stop us in our tracks. The “Person-Centered Matters” video about people living with dementia and those…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    FDA Approves Revolutionary Approach to Cancer Treatment

    The Leukemia and Lymphoma Society Nov 13, 2017

    The Leukemia & Lymphoma Society (LLS) hails today’s U.S. Food and Drug Administration (FDA) approval of a new, personalized cell therapy that supercharges the patient’s immune system to find and…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    3 Ways to End Preventable Child Deaths from Pneumonia

    Devex International Development Nov 13, 2017

    Despite recent mobilization of funding and targeted interventions by donors, nongovernmental organisations, and the private and public sectors between 2005 and 2015, much more needs to be done to end preventable child deaths by…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    Looking for a Breast Cancer Breakthrough

    Fred Hutchinson Cancer Research Center Nov 13, 2017

    Dr. Ruth Etzioni, a biostatistician in Fred Hutchinson Cancer Research Center’s Public Health Sciences Division, has received a five-year National Institutes of Health grant to advance the science of cancer…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    A New Option for High-Risk Multiple Myeloma?

    Fred Hutchinson Cancer Research Center Nov 12, 2017

    Six years ago, Todd Hirai learned why all the physical therapy he’d received for his baseball injury hadn’t eased his back pain. He hadn’t wrenched his back in the batting…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    Development of ALS Biomarkers

    PRWeb Nov 11, 2017

    A prognostic test for ALS (amyotrophic lateral sclerosis) could help improve and accelerate clinical trials and speed the development of life-saving drugs to people with ALS. Reports suggest approximately 30,000…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    FDA Approves Second CAR T-cell Immunotherapy for Cancer

    CNBC Nov 11, 2017

    U.S. Food and Drug Administration (FDA) approval of a new, personalized cell therapy that supercharges the patient’s immune system to find and kill cancer cells. The therapy, axicabtagene ciloleucel (Yescarta…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    Global TB Efforts Turn to Innovative Finance

    Devex International Development Nov 11, 2017

    The fight against tuberculosis is the latest effort to investigate innovative financing instruments for vital funding. The Global Fund to Fight AIDS, Tuberculosis and Malaria and the International Union against Tuberculosis…

    •  Share
    • Save
    Share
  • This article is deemed a must-read by one or more of our expert collaborators.
    Click here for more.

    Innovation in Alzheimer’s Clinical Trials

    PR Newswire Nov 10, 2017

    There are 126 drugs in clinical development for Alzheimer’s disease and “every single one represents hope,” according to Closing in on a Cure: 2017 Alzheimer’s Clinical Trials Report. The report, released…

    •  Share
    • Save
    Share
Newer Posts
Older Posts
Topics
Location
Date
Type
Date
Min. Investment
Show Only
Radius
Follow Us
Newsletter

Become a newsletter subscriber to stay up-to-date on the latest Giving Compass news.

About Us
  • About Giving Compass
  • In The News
  • Content at Giving Compass
Giving Compass Network
  • Giving Compass
  • X4Impact
Partnerships & Services
  • Nonprofits
  • Authors
  • Partner With Us
  • Contact Us

We are a nonprofit too. Donate to Giving Compass to help us guide donors toward practices that advance equity.

loyaltyDonate to Giving Compass
Trending Issues
  • Climate
  • Democracy
  • Education
  • Homelessness
  • Reproductive Justice
  • Copyright © 2026, Giving Compass Network
  • A 501(c)(3) organization. EIN: 85-1311683
  • Privacy Policy
  • User Agreement

Sign in

Don't have an account?
Click here to sign up!

Your personal information is confidential at Giving Compass. For more information, please visit our privacy policy. By signing up, you agree to our terms of use.